Home Active Agrochemical IngredientAgrochemicals Alembic Pharma seeds down in US biotech RIGImmune

Alembic Pharma seeds down in US biotech RIGImmune

by admin
0 comment
Alembic, Pharma, RIGImmune, Stakes , US, India , Company, Biotech, Doctors, RNA, Virus

Synopsis-

  • Alembic said it has acquired preferred stock in RIGImmune amounting to a 19.97% post-money stake in the first closing of the series seed round that was completed recently.
  • The biotech was founded by Dr. Anna Pyle and Dr. Akiko Iwasaki is focused on the development of RNA based therapies for viral diseases and oncology applications by targeting the innate immune target, RIG-I.

Alembic Pharma on Friday announced that it has made a strategic investment in RIGImmune, a biopharmaceutical research company co-founded by two prominent Yale University professors that’s focused on the development of novel treatments for  RNA Virus.

Alembic said it has acquired preferred stock in RIGImmune amounting to a 19.97% post-money stake in the first closing of the series seed round that was completely  recently.

  Alembic, Pharma, RIGImmune, Stakes , US, India , Company, Biotech, Doctors, RNA, Virus


Alembic Pharma buys Stock in RIGImmune Inc.

The biotech was founded by Dr. Anna Pyle and Dr. Akiko Iwasaki is focused on the development of RNA based therapies for viral diseases and oncology applications by targeting the innate immune target, RIG-I.

RIGImmune will utilize the proceeds of the series seed round to further the development  of therapeutic oligonucleotides developed by Pyle and Iwasaki.

Both Pyle and Iwasaki were professors at Yale University and are investigators for  the Howard Hughes Medical Institute. They were considered pioneers in the field  of immunology .

“We are very excited to make this investment in RIGImmune Inc., a company founded by two of the world’s leading scientists in innate immunity and RNA based therapies,” Pranav Amin, MD of Alembic.

“We are delighted to have Alembic, a global pharmaceutical development firm, as  a major participant in the seed financing round for RIGImmune,” said Martin Driscoll, Chairman of the Board of Directors for RIGImmune.

 

 About Alembic Pharma

Alembic Pharmaceuticals Ltd. is an Indian multinational pharmaceutical company headquartered in Vadodara city of Gujarat – India.  Alembic Pharmaceuticals Ltd. is involved in manufacture of pharmaceutical products, pharmaceutical substances and intermediates. It is also termed to be a market leader in macrolides segment of anti-infective drugs in India.

The company has its headquarters and Corporate Office situated in Vadodara, Gujarat – India while its manufacturing facilities are located at Panelav, Karakhadi in Gujarat and Sikkim, India. Its Panelav plant houses active pharmaceutical ingredients (APIs) and formulation manufacturing, while its Sikkim plant is involved in manufacture of formulations for Indian and non-regulated export markets

 

About  RIGImmune

Founded by two doctors and professors at Yale University, RIGImmune Inc focusses on the development of RNA-based therapies for viral diseases and oncology applications by targetting the innate immune target, RIG-I. RIGImmune will utilise the proceeds of the series seed round to further the development of therapeutic

 

For more Information: Sign in Websites for Agrochemical & Pharmaceutical Databases:

Website : https://www.chemrobotics.com/ (Agrochemical Databases)

Website : https://chemroboticspharma.com/  (Pharmaceutical Databases)

 

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Our Company

Lorem ipsum dolor sit amet, consect etur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis.

ChemRobotics Times

Subscribe my Newsletter for new blog posts, tips & new photos. Let's stay updated!

Laest News

@2021 – All Right Reserved. Designed and Developed by Ample eBusiness

WP2Social Auto Publish Powered By : XYZScripts.com